We are home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® continuous glucose monitoring systems from Senseonics.
* Not a guarantee of coverage and payment. A doctor's prescription is required for Medicare coverage and patients must meet Medicare eligibility coverage criteria. Coverage and payment may be subject to coinsurance, deductible and patient eligibility requirements. Visit https://www.medicare.gov to learn more about Medicare plans and coverage.
** Offer valid for eligible privately insured patients only. Purchase of CONTOUR®NEXT Test Strips required. Limitations and restrictions apply.
† #1 Brand in Medicare Patient Satisfaction claim is from data collected from June 8 through June 15, 2020.
‡ Check with your insurance provider as they may provide a lower cost option.
§ Up to 6 months.
¶ The offers above only apply to the cost of the sensor and transmitter or sensor. They do not cover the cost of the insertion or removal procedure. Limitations and Restrictions may apply. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice.
1. Ascensia Diabetes Care. Data on File. OTC brand volume (October 2020), IRI Cash Data CYTD accessed November 2020.
2. Christiansen, M. P. (2017). A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology, 11(3), 567-573. DOI: 10.1177/1932296817691301
The information brought to you by Ascensia Diabetes Care US Inc. provides general information. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of your Healthcare Provider.